These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17242279)

  • 1. Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction.
    Vanhoutte D; Schellings MW; Götte M; Swinnen M; Herias V; Wild MK; Vestweber D; Chorianopoulos E; Cortés V; Rigotti A; Stepp MA; Van de Werf F; Carmeliet P; Pinto YM; Heymans S
    Circulation; 2007 Jan; 115(4):475-82. PubMed ID: 17242279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse strain determines the outcome of wound healing after myocardial infarction.
    van den Borne SW; van de Schans VA; Strzelecka AE; Vervoort-Peters HT; Lijnen PM; Cleutjens JP; Smits JF; Daemen MJ; Janssen BJ; Blankesteijn WM
    Cardiovasc Res; 2009 Nov; 84(2):273-82. PubMed ID: 19542177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
    Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice.
    Cavasin MA; Tao Z; Menon S; Yang XP
    Life Sci; 2004 Sep; 75(18):2181-92. PubMed ID: 15325844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction.
    Tsujita K; Kaikita K; Hayasaki T; Honda T; Kobayashi H; Sakashita N; Suzuki H; Kodama T; Ogawa H; Takeya M
    Circulation; 2007 Apr; 115(14):1904-11. PubMed ID: 17389263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.
    Angoulvant D; Fazel S; Weisel RD; Lai TY; Fedak PW; Chen L; Rafati S; Seneviratne CK; Degousee N; Li RK
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):471-80. PubMed ID: 19185172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biglycan is required for adaptive remodeling after myocardial infarction.
    Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann SM; Young MF; Schultheiss HP; Levkau B; Baba HA; Unger T; Zacharowski K; Tschöpe C; Fischer JW
    Circulation; 2008 Mar; 117(10):1269-76. PubMed ID: 18299507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
    Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
    Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
    Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction.
    Fang L; Gao XM; Samuel CS; Su Y; Lim YL; Dart AM; Du XJ
    Clin Sci (Lond); 2008 Aug; 115(3):99-106. PubMed ID: 18248324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling.
    Finsen AV; Woldbaek PR; Li J; Wu J; Lyberg T; Tønnessen T; Christensen G
    Physiol Genomics; 2004 Feb; 16(3):301-8. PubMed ID: 14625378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
    Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G
    Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling.
    Gurantz D; Yndestad A; Halvorsen B; Lunde OV; Omens JH; Ueland T; Aukrust P; Moore CD; Kjekshus J; Greenberg BH
    Cardiovasc Res; 2005 Jul; 67(1):106-15. PubMed ID: 15949474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
    Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
    Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.
    Tian H; Cimini M; Fedak PW; Altamentova S; Fazel S; Huang ML; Weisel RD; Li RK
    J Mol Cell Cardiol; 2007 Dec; 43(6):733-43. PubMed ID: 17945252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells.
    Maekawa Y; Mizue N; Chan A; Shi Y; Liu Y; Dawood S; Chen M; Dawood F; de Couto G; Li GH; Suzuki N; Yeh WC; Gramolini A; Medin JA; Liu PP
    Circulation; 2009 Oct; 120(14):1401-14. PubMed ID: 19770394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of thrombospondin-2 causes age-related dilated cardiomyopathy.
    Swinnen M; Vanhoutte D; Van Almen GC; Hamdani N; Schellings MW; D'hooge J; Van der Velden J; Weaver MS; Sage EH; Bornstein P; Verheyen FK; VandenDriessche T; Chuah MK; Westermann D; Paulus WJ; Van de Werf F; Schroen B; Carmeliet P; Pinto YM; Heymans S
    Circulation; 2009 Oct; 120(16):1585-97. PubMed ID: 19805649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.
    Xu X; Wan W; Ji L; Lao S; Powers AS; Zhao W; Erikson JM; Zhang JQ
    Cardiovasc Res; 2008 Jun; 78(3):523-32. PubMed ID: 18252761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-1 amplifies angiotensin II-induced cardiac fibrosis.
    Schellings MW; Vanhoutte D; van Almen GC; Swinnen M; Leenders JJ; Kubben N; van Leeuwen RE; Hofstra L; Heymans S; Pinto YM
    Hypertension; 2010 Feb; 55(2):249-56. PubMed ID: 20048198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.